FI20000084L - Menetelmä sieniä tuhoavan farmaseuttisen koostumuksen valmistamiseksi - Google Patents

Menetelmä sieniä tuhoavan farmaseuttisen koostumuksen valmistamiseksi Download PDF

Info

Publication number
FI20000084L
FI20000084L FI20000084A FI20000084A FI20000084L FI 20000084 L FI20000084 L FI 20000084L FI 20000084 A FI20000084 A FI 20000084A FI 20000084 A FI20000084 A FI 20000084A FI 20000084 L FI20000084 L FI 20000084L
Authority
FI
Finland
Prior art keywords
preparing
pharmaceutical composition
antifungal pharmaceutical
antifungal
composition
Prior art date
Application number
FI20000084A
Other languages
English (en)
Swedish (sv)
Other versions
FI20000084A7 (fi
Inventor
Stephen James Ray
Kenneth Richardson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10670334&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI20000084(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of FI20000084A7 publication Critical patent/FI20000084A7/fi
Publication of FI20000084L publication Critical patent/FI20000084L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI20000084A 1990-02-02 2000-01-17 Menetelmä sieniä tuhoavan farmaseuttisen koostumuksen valmistamiseksi FI20000084L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909002375A GB9002375D0 (en) 1990-02-02 1990-02-02 Triazole antifungal agents

Publications (2)

Publication Number Publication Date
FI20000084A7 FI20000084A7 (fi) 2000-01-17
FI20000084L true FI20000084L (fi) 2000-01-17

Family

ID=10670334

Family Applications (3)

Application Number Title Priority Date Filing Date
FI910508A FI107608B (fi) 1990-02-02 1991-02-01 Menetelmä antifungaalisen yhdisteen valmistamiseksi sekä menetelmässä käytettävät välituotteet
FI971238A FI971238A7 (fi) 1990-02-02 1991-02-01 Triatsolisienitautilääkkeet
FI20000084A FI20000084L (fi) 1990-02-02 2000-01-17 Menetelmä sieniä tuhoavan farmaseuttisen koostumuksen valmistamiseksi

Family Applications Before (2)

Application Number Title Priority Date Filing Date
FI910508A FI107608B (fi) 1990-02-02 1991-02-01 Menetelmä antifungaalisen yhdisteen valmistamiseksi sekä menetelmässä käytettävät välituotteet
FI971238A FI971238A7 (fi) 1990-02-02 1991-02-01 Triatsolisienitautilääkkeet

Country Status (42)

Country Link
US (2) US5567817A (fi)
EP (1) EP0440372B1 (fi)
JP (2) JP2625584B2 (fi)
KR (1) KR930011039B1 (fi)
CN (2) CN1026788C (fi)
AP (2) AP9000237A0 (fi)
AT (1) ATE90090T1 (fi)
AU (1) AU625188B2 (fi)
BA (1) BA97298A (fi)
BG (1) BG60032B2 (fi)
BR (1) BR9100435A (fi)
CA (2) CA2035314C (fi)
CZ (1) CZ279339B6 (fi)
DE (2) DE69100095T2 (fi)
DK (1) DK0440372T3 (fi)
EG (1) EG19750A (fi)
ES (1) ES2055523T4 (fi)
FI (3) FI107608B (fi)
GB (1) GB9002375D0 (fi)
HK (1) HK219396A (fi)
HU (2) HU205351B (fi)
IE (1) IE64774B1 (fi)
IL (2) IL97045A (fi)
IN (1) IN176148B (fi)
IS (1) IS1629B (fi)
LU (1) LU90960I2 (fi)
LV (1) LV10615B (fi)
MA (1) MA22054A1 (fi)
MX (1) MX24363A (fi)
MY (1) MY105494A (fi)
NL (1) NL300100I2 (fi)
NO (2) NO176796C (fi)
NZ (1) NZ247205A (fi)
OA (1) OA09480A (fi)
PE (1) PE31691A1 (fi)
PL (3) PL169332B1 (fi)
PT (1) PT96617B (fi)
RO (1) RO109648B1 (fi)
RU (2) RU2114838C1 (fi)
SK (1) SK278215B6 (fi)
YU (1) YU48105B (fi)
ZA (1) ZA91761B (fi)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9002375D0 (en) * 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
GB9121456D0 (en) * 1991-10-10 1991-11-27 Pfizer Ltd Triazole antifungal agents
GB2281297A (en) * 1993-08-27 1995-03-01 Merck & Co Inc Quinazoline compounds
NZ270418A (en) * 1994-02-07 1997-09-22 Eisai Co Ltd Polycyclic triazole & imidazole derivatives, antifungal compositions
DE19500379A1 (de) * 1995-01-09 1996-07-11 Basf Ag Fluorierte Pyrimidine als Herbizide
GB9516121D0 (en) 1995-08-05 1995-10-04 Pfizer Ltd Organometallic addition to ketones
GB9602080D0 (en) * 1996-02-02 1996-04-03 Pfizer Ltd Pharmaceutical compounds
GB9605705D0 (en) * 1996-03-19 1996-05-22 Pfizer Ltd Therapeutic agents
BR9711167A (pt) * 1996-05-24 1999-08-17 Schering Corp Composi-Æo antifÚngica com maior biodisponibilidade
US7193083B2 (en) * 1996-07-26 2007-03-20 Pfizer, Inc. Preparation of triazoles by organometallic addition to ketones and intermediates therefor
GB9713149D0 (en) * 1997-06-21 1997-08-27 Pfizer Ltd Pharmaceutical formulations
CN1081189C (zh) * 1998-07-17 2002-03-20 国家医药管理局四川抗菌素工业研究所 唑醇类新衍生物及其制备方法和医药用途
GB9818258D0 (en) * 1998-08-21 1998-10-14 Pfizer Ltd Antifungal compositions
AU5871000A (en) * 1999-06-11 2001-01-02 Paul G. Abrams High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) * 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
US6391903B1 (en) * 1999-09-09 2002-05-21 Sankyo Company, Limited Triazole derivatives having antifungal activity
US6362172B2 (en) * 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
US6319933B1 (en) 2000-04-17 2001-11-20 Basilea Pharmaceutica Ag Azole derivatives
WO2002062398A2 (en) * 2001-01-08 2002-08-15 Neorx Corporation Radioactively labelled conjugates of phosphonates
HUP0303249A3 (en) 2001-02-22 2007-03-28 Sankyo Co Water-soluble triazole fungicide compounds and pharmaceutical compositions containing them
AU2002364552A1 (en) 2001-12-13 2003-06-30 Dow Global Technologies Inc. Treatment of osteomyelitis with radiopharmaceuticals
CA2477088A1 (en) 2002-02-22 2003-10-02 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
CN100379733C (zh) * 2002-10-08 2008-04-09 南京康泽医药科技有限公司 三唑类抗真菌药物及其制备方法
US20040098839A1 (en) * 2002-11-27 2004-05-27 Pfizer Inc. Crystallization method and apparatus using an impinging plate assembly
WO2006065726A2 (en) 2004-12-14 2006-06-22 Dr. Reddy's Laboratories Ltd. Process for preparing voriconazole
JP5055263B2 (ja) 2005-03-30 2012-10-24 ダエウン ファーマシューティカル カンパニー リミテッド 抗真菌性トリアゾール誘導体
EP2024344A2 (en) * 2006-02-01 2009-02-18 Medichem, S.A. Process for preparing voriconazole, new polymorphic form of intermediate thereof, and uses thereof
AR061889A1 (es) 2006-07-13 2008-10-01 Medichem Sa Proceso mejorado para la preparacion de voriconazol
CN1919846B (zh) * 2006-09-14 2013-01-02 大道隆达（北京）医药科技发展有限公司 伏立康唑及其药用盐、中间体的一种新定向合成制备方法
JP2010510248A (ja) * 2006-11-21 2010-04-02 ビアメト ファーマシューティカルズ，インク． 金属結合部分をターゲティング部分と組み合わせて使用する金属酸化還元酵素阻害剤
KR100889937B1 (ko) 2007-08-06 2009-03-20 한미약품 주식회사 보리코나졸의 제조방법
GB2452049A (en) * 2007-08-21 2009-02-25 Alpharma Aps Process for the preparation of voriconazole
CN101575330B (zh) * 2008-05-05 2012-10-31 丽珠医药集团股份有限公司 伏立康唑广谱抗真菌药物化合物、其组合物及用途
WO2009137611A2 (en) * 2008-05-06 2009-11-12 Board Of Regents, The University Of Texas System Treatment of pulmonary fungal infection with voriconazole via inhalation
JP2009286756A (ja) 2008-05-30 2009-12-10 Fujifilm Finechemicals Co Ltd トリアゾール誘導体またはその塩
WO2010084505A2 (en) * 2008-06-06 2010-07-29 Glenmark Pharmaceuticals Limited Stable topical formulation comprising voriconazole
WO2010095145A1 (en) * 2009-02-17 2010-08-26 Glenmark Generics Limited Process for the preparation of voriconazole
KR101109215B1 (ko) 2009-06-17 2012-01-30 보령제약 주식회사 보리코나졸의 신규 중간체 및 이를 이용한 보리코나졸의 제조방법
WO2011020605A1 (en) 2009-08-19 2011-02-24 Ratiopharm Gmbh Process for the production of coevaporates and complexes comprising voriconazole and cyclodextrin
DK3403654T3 (da) 2009-10-01 2019-08-26 Adare Dev I L P Oralt administrerede kortikosteroidsammensætninger
WO2011064558A2 (en) 2009-11-30 2011-06-03 Cipla Limited Pharmaceutical composition
MTP4285B (en) 2009-12-30 2011-07-04 Medichem Sa A 1-(1h-1,2,3-triazol-1-yl)butan-2-ol derivative for pharmaceutical use, and the use of a 1-(1h-1, 2, 4- triazol-1yl) butan-2-ol derivative with substially undefined crystal shap for preparing said 1-(1h-1, 2, 4-triazol-1-yl0 butan-2-ol derivative
KR100971371B1 (ko) 2010-02-04 2010-07-20 동국제약 주식회사 신규한 중간체를 이용한 보리코나졸의 제조방법
EP2545039A1 (en) 2010-03-10 2013-01-16 Synthon BV A process for making voriconazole
EP2409699B1 (en) * 2010-07-23 2014-04-30 Combino Pharm, S.L. Stable compositions of voriconazole
CN101914091B (zh) * 2010-07-25 2015-05-27 浙江华海药业股份有限公司 一种制备伏立康唑中间体的方法
AU2012221788A1 (en) 2011-02-21 2013-09-05 Sun Pharmaceutical Industries Limited An improved process for the preparation of voriconazole and intermediates thereof
WO2012171561A1 (en) 2011-06-15 2012-12-20 Synthon Bv Stabilized voriconazole composition
EP2561863A1 (en) 2011-08-22 2013-02-27 Farmaprojects, S.A.U. Pharmaceutical compositions comprising voriconazole
RU2014149993A (ru) 2012-05-11 2016-07-10 Сипла Лимитед Фармацевтическая композиция
SI2906555T1 (sl) * 2012-10-15 2017-02-28 Pfizer Ireland Pharmaceuticals Operations Support Group Postopek za pripravo vorikonazola in njegovih analogov
CN105102443B (zh) * 2013-02-04 2017-07-28 先正达参股股份有限公司 新颖的杀微生物剂
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
JP6262972B2 (ja) * 2013-09-17 2018-01-17 公益財団法人微生物化学研究会 化合物、及びその製造方法、並びにボリコナゾールの製造方法
JP2018511608A (ja) * 2015-04-02 2018-04-26 バイエル・クロップサイエンス・アクチェンゲゼルシャフト 殺真菌剤としてのトリアゾール誘導体
CN104987325B (zh) * 2015-06-30 2017-03-29 扬子江药业集团南京海陵药业有限公司 一种伏立康唑的制备方法
CN106117186B (zh) * 2016-06-12 2018-08-24 重庆莱美隆宇药业有限公司 一种伏立康唑及其中间体的制备方法
CN107556294A (zh) * 2016-06-30 2018-01-09 陕西合成药业股份有限公司 一种新型抗真菌感染药物及其制备方法和用途
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
SG10202105118WA (en) * 2016-11-28 2021-06-29 Cellix Bio Private Ltd Compositions and methods for the treatment of fungal infections
US11185548B2 (en) 2016-12-23 2021-11-30 Helmholtz Zentrum Munchen—Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) Inhibitors of cytochrome P450 family 7 subfamily B member 1 (CYP7B1) for use in treating diseases
US11040958B2 (en) * 2017-02-17 2021-06-22 Wuhan Ll Science And Technology Development Co., Ltd. Triazole antimicrobial derivative, pharmaceutical composition and use thereof
CN109705102A (zh) 2019-02-19 2019-05-03 浙江华海立诚药业有限公司 伏立康唑及其中间体的制备方法
CN111440152B (zh) * 2020-05-18 2022-09-27 浙江诚意药业股份有限公司 一种伏立康唑的制备方法
CN112079819B (zh) * 2020-09-24 2022-06-17 南京易亨制药有限公司 一种改进的伏立康唑消旋体制备方法
CN114907319B (zh) * 2021-02-06 2024-06-14 华创合成制药股份有限公司 一种氘代三唑类化合物及其制备方法和用途
CN117069693A (zh) * 2022-05-16 2023-11-17 上海济煜医药科技有限公司 一类含胺基结构化合物的制备方法及作为抗菌剂的应用
CN115724829A (zh) * 2022-12-23 2023-03-03 天津力生制药股份有限公司 一种分离真菌药物中间体杂质的液相色谱制备方法
CN116730985A (zh) * 2023-06-20 2023-09-12 天津力生制药股份有限公司 一锅法制备伏立康唑的合成方法
CN118307408B (zh) * 2024-04-10 2025-03-21 上海恩氟佳科技有限公司 2-氟丙酰乙酸乙酯的制备方法

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000138A (en) * 1966-03-31 1976-12-28 Imperial Chemical Industries Limited Organic compounds and compositions containing them
US3980781A (en) * 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
DE2431407C2 (de) * 1974-06-29 1982-12-02 Bayer Ag, 5090 Leverkusen 1,2,4-Triazol-1-yl-alkanone und -alkanole, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Fungizide
US4654332A (en) * 1979-03-07 1987-03-31 Imperial Chemical Industries Plc Heterocyclic compounds
US4927839A (en) * 1979-03-07 1990-05-22 Imperial Chemical Industries Plc Method of preventing fungal attack on wood, hides, leather or paint films using a triazole
US4551469A (en) * 1979-03-07 1985-11-05 Imperial Chemical Industries Plc Antifungal triazole ethanol derivatives
US4259505A (en) * 1980-03-04 1981-03-31 Ciba-Geigy Corporation Process for the preparation of 1H-azole derivatives
GB2078719B (en) * 1980-06-02 1984-04-26 Ici Ltd Heterocyclic compounds
US5395942A (en) * 1980-06-02 1995-03-07 Zeneca Limited Heterocyclic compounds
DE3177275D1 (de) * 1980-08-18 1992-04-16 Ici Plc Verwendung von triazolylaethanol-derivate und deren zusammensetzungen als nichtlandwirtschaftliche fungizide.
DE3175673D1 (en) * 1980-11-19 1987-01-15 Ici Plc Triazole compounds, a process for preparing them, their use as plant fungicides and fungicidal compositions containing them
US5466821A (en) * 1981-03-18 1995-11-14 Zeneca Limited Heterocyclic compounds
EP0061835B1 (en) * 1981-03-18 1989-02-01 Imperial Chemical Industries Plc Triazole compounds, a process for preparing them, their use as plant fungicides and fungicidal compositions containing them
US5204363A (en) * 1981-03-18 1993-04-20 Imperial Chemical Industries Plc Heterocyclic compounds
DE3262386D1 (en) * 1981-06-06 1985-03-28 Pfizer Ltd Antifungal agents, processes for their preparation, and pharmaceutical compositions containing them
US4510148A (en) * 1982-06-12 1985-04-09 Pfizer Inc. 2-Heterocyclic-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ols as antifungal agents
ES8503680A1 (es) * 1982-06-17 1985-04-01 Pfizer Un procedimiento para la preparacion de un compuesto dotado de propiedades fungicidas
DE3228870A1 (de) * 1982-08-03 1984-02-09 Bayer Ag, 5090 Leverkusen Diazolyl-alkanole, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
US4505919A (en) * 1982-10-09 1985-03-19 Pfizer Inc. Antifungal S-arylmethyl- and S-heterocyclylmethyl ethers of 2-aryl-3-mercapto-1-(1H-1,2,4-triazol-1-yl) propan-2-ols
DE3242236A1 (de) * 1982-11-15 1984-05-17 Bayer Ag, 5090 Leverkusen "antimykotische mittel"
DE3242252A1 (de) * 1982-11-15 1984-05-17 Bayer Ag, 5090 Leverkusen Heterocyclisch substituierte hydroxyalkyl-azolyl-derivate
DE3245504A1 (de) * 1982-12-09 1984-06-14 Bayer Ag, 5090 Leverkusen Fungizide mittel, deren herstellung und verwendung
GB8301699D0 (en) * 1983-01-21 1983-02-23 Pfizer Ltd Antifungal agents
DE3307218A1 (de) * 1983-03-02 1984-09-06 Bayer Ag, 5090 Leverkusen Substituierte diazolylalkyl-carbinole, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
GB8306351D0 (en) * 1983-03-08 1983-04-13 Ici Plc Azole fungicides
JPS59142480U (ja) * 1983-03-15 1984-09-22 サンデン株式会社 スクロ−ル型流体装置
GR81556B (fi) * 1983-05-09 1984-12-11 Stauffer Chemical Co
DE3325313A1 (de) * 1983-07-13 1985-01-31 Bayer Ag, 5090 Leverkusen Fungizide mittel, deren herstellung und verwendung
US4483863A (en) * 1984-01-20 1984-11-20 Pfizer Inc. Triazole antifungal agents
US4602025A (en) * 1984-06-18 1986-07-22 Eli Lilly And Company Aromatase inhibitors
US4801594A (en) * 1984-06-18 1989-01-31 Eli Lilly And Company Aromatase inhibitors
US4605661A (en) * 1984-06-18 1986-08-12 Eli Lilly And Company Aromastase inhibiting α,α-diarylimidazole-4(5)-propionitriles, α,α-diarylimidazole-4(5)-propionamides, and 4(5)-(2,2-diarylethyl)imidazoles
IE58738B1 (en) * 1984-09-05 1993-11-03 Ici Plc Antifungal azole compounds
GB8424799D0 (en) * 1984-10-02 1984-11-07 Ici Plc Biocide composition
GB8506619D0 (en) * 1985-03-14 1985-04-17 Pfizer Ltd Triazole antifungal agents
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
US5084465A (en) * 1986-06-23 1992-01-28 Du Pont Merck Pharmaceutical Company Antifungal carbinols
US4952232A (en) * 1987-04-29 1990-08-28 E. I. Du Pont De Nemours And Company Antifungal carbinols
DE3784787T2 (de) * 1986-06-23 1994-01-20 Du Pont Merck Pharma Fungizide Karbinole.
US4980367A (en) * 1987-12-17 1990-12-25 E. I. Du Pont De Nemours And Company Antifungal carbinols
US4965281A (en) * 1986-06-23 1990-10-23 E. I. Du Pont De Nemours And Cmopany Antifungal carbinols
US4876259A (en) * 1987-01-05 1989-10-24 E. I. Du Pont De Nemours And Company 3,3-disubstituted indolines
EP0279263B1 (en) * 1987-02-10 1993-08-04 Abbott Laboratories Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds
DE3813841A1 (de) * 1987-06-03 1988-12-15 Bayer Ag Heterocyclische hydroxyethylazole
GB8716651D0 (en) * 1987-07-15 1987-08-19 Ici Plc 2-propanol derivatives
GB8729083D0 (en) * 1987-12-12 1988-01-27 Pfizer Ltd Triazole antifungal agents
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
DE3806089A1 (de) * 1988-02-26 1989-09-07 Basf Ag Azolylmethyloxirane und diese enthaltende fungizide
HUT53889A (en) * 1988-03-04 1990-12-28 Sankyo Co. Ltd.,Jp Fungicides comprising triazole derivatives as active ingredient and process for producing the active ingredient
DE3809069A1 (de) * 1988-03-18 1989-09-28 Basf Ag Azolylmethylallylalkohole und diese enthaltende fungizide
GB8819308D0 (en) * 1988-08-13 1988-09-14 Pfizer Ltd Triazole antifungal agents
GB9002375D0 (en) * 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
US5278175A (en) * 1990-02-02 1994-01-11 Pfizer Inc. Triazole antifungal agents
KR900016822A (ko) * 1990-04-20 1990-11-14 하라 레이노스께 슬라이드 프로젝터
US5132319A (en) * 1991-03-28 1992-07-21 Merck Frosst Canada, Inc. 1-(hydroxylaminoalkyl) indole derivatives as inhibitors of leukotriene biosynthesis
US5205354A (en) * 1992-01-28 1993-04-27 Lesage Philip G Vehicle radiator and method of making
EP0613890A1 (en) * 1993-02-28 1994-09-07 Nihon Nohyaku Co., Ltd. Novel triazole compound, process for preparing the same and antifungal agent containing the same
NZ270418A (en) * 1994-02-07 1997-09-22 Eisai Co Ltd Polycyclic triazole & imidazole derivatives, antifungal compositions
DE4408404A1 (de) * 1994-03-12 1995-09-14 Huels Chemische Werke Ag Verfahren zur Herstellung von Chlorpyrimidinen
CA2145458A1 (en) * 1994-03-28 1995-09-29 Hiroki Kodama Triazole compound and production process and use thereof
DE69616027T2 (de) * 1995-01-30 2002-05-16 Syngenta Ltd., Haselmere Verfahren zur herstellung von 4,6-dichloro-pyrimidine

Also Published As

Publication number Publication date
RU2036194C1 (ru) 1995-05-27
PL288901A1 (en) 1992-01-27
US5773443A (en) 1998-06-30
PT96617A (pt) 1991-10-15
NL300100I2 (nl) 2003-01-06
RO109648B1 (ro) 1995-04-28
DK0440372T3 (da) 1993-06-28
FI20000084A7 (fi) 2000-01-17
HK219396A (en) 1997-01-03
IS3671A7 (is) 1991-08-03
IL110322A0 (en) 1994-10-21
NO176796B (no) 1995-02-20
BG60032B2 (bg) 1993-07-30
MX24363A (es) 1993-09-01
SK278215B6 (en) 1996-04-03
ATE90090T1 (de) 1993-06-15
OA09480A (fr) 1992-11-15
US5567817A (en) 1996-10-22
KR910021398A (ko) 1991-12-20
JPH04211078A (ja) 1992-08-03
IS1629B (is) 1996-07-19
AU625188B2 (en) 1992-07-02
RU2114838C1 (ru) 1998-07-10
IE64774B1 (en) 1995-09-06
JP2625584B2 (ja) 1997-07-02
HUT56361A (en) 1991-08-28
YU48105B (sh) 1997-03-07
HU211582A9 (en) 1995-12-28
BR9100435A (pt) 1991-10-22
NO910368L (no) 1991-08-05
CA2035314A1 (en) 1991-08-03
CA2285891C (en) 2004-01-06
LU90960I2 (fr) 2003-04-02
PL169307B1 (pl) 1996-06-28
KR930011039B1 (ko) 1993-11-20
NL300100I1 (nl) 2002-11-01
HU205351B (en) 1992-04-28
DE69100095T2 (de) 1993-09-09
CA2285891A1 (en) 1991-08-03
CA2035314C (en) 2000-01-18
FI971238L (fi) 1997-03-25
PL169332B1 (pl) 1996-07-31
NO2002006I2 (no) 2004-10-11
MA22054A1 (fr) 1991-10-01
JPH09208583A (ja) 1997-08-12
YU17591A (sh) 1994-01-20
ES2055523T4 (es) 2011-04-11
NZ247205A (en) 1993-09-27
NO176796C (no) 1995-05-31
FI910508A0 (fi) 1991-02-01
JP2848811B2 (ja) 1999-01-20
FI910508L (fi) 1991-08-03
AU7022391A (en) 1991-09-05
DE10299035I2 (de) 2003-06-26
FI971238A0 (fi) 1997-03-25
EG19750A (en) 1996-01-31
CZ279339B6 (cs) 1995-04-12
DE69100095D1 (de) 1993-07-08
EP0440372B1 (en) 1993-06-02
ES2055523T3 (es) 1994-08-16
AP9000237A0 (en) 1991-01-31
MY105494A (en) 1994-10-31
PE31691A1 (es) 1991-11-29
FI971238A7 (fi) 1997-03-25
FI107608B (fi) 2001-09-14
BA97298A (bs) 2001-09-14
CS9100249A2 (en) 1991-09-15
NO910368D0 (no) 1991-01-31
AP223A (en) 1992-08-27
PT96617B (pt) 1998-07-31
DE10299035I1 (de) 2003-05-22
ZA91761B (en) 1992-09-30
IL97045A (en) 1995-11-27
PL167294B1 (pl) 1995-08-31
LV10615A (lv) 1995-04-20
CN1040504C (zh) 1998-11-04
LV10615B (en) 1995-12-20
IE910342A1 (en) 1991-08-14
IN176148B (fi) 1996-02-10
CN1053787A (zh) 1991-08-14
IL110322A (en) 1996-10-31
CN1026788C (zh) 1994-11-30
GB9002375D0 (en) 1990-04-04
CN1100421A (zh) 1995-03-22
IL97045A0 (en) 1992-03-29
EP0440372A1 (en) 1991-08-07

Similar Documents

Publication Publication Date Title
FI20000084L (fi) Menetelmä sieniä tuhoavan farmaseuttisen koostumuksen valmistamiseksi
FI914398A7 (fi) Menetelmä farmaseuttisen kokoonpanon valmistamiseksi
FI906249A7 (fi) Menetelmä farmaseuttisen seoksen valmistamiseksi
FI911522A7 (fi) Menetelmä nestestabiilin yhdistelmien valmistamiseksi
FI893520L (fi) Menetelmä intravenoosisen farmaseuttisen koostumuksen valmistamiseksi
FI933357A7 (fi) Menetelmä benzamidien valmistamiseksi
FI905682L (fi) Menetelmä hidastetusti vapauttavien koostumusten valmistamiseksi
FI921021A7 (fi) Menetelmä trans-Pt(IV)-yhdisteiden valmistamiseksi
FI921174L (fi) Menetelmä metyylieetterien valmistamiseksi
FI911601L (fi) Menetelmä pigmentin valmistamiseksi
FI912109A7 (fi) Menetelmä polymeerikoostumuksen valmistamiseksi
FI925988A7 (fi) Menetelmä B-laktaamien valmistamiseksi
FI911131L (fi) Menetelmä viherkaihia estävien 3-aryylikarbonyyli-1-aminoalkyyli-1H-indoliyhdisteiden valmistamiseksi
FI905681L (fi) Menetelmä hidastetusti vapauttavien koostumusten valmistamiseksi
FI940280L (fi) Menetelmä demetyyliepypodofyylilotoksiinin valmistamiseksi
FI20001776A7 (fi) Menetelmä farmaseuttisen koostumuksen valmistamiseksi
FI912868A7 (fi) Menetelmä farmaseuttisten yhdisteiden valmistamiseksi
FI923498A7 (fi) Menetelmä 3-deoksimannosamiini-johdannaisten valmistamiseksi
FI903698A7 (fi) Menetelmä asfalttimassan valmistamiseksi
FI913554L (fi) Menetelmä stabiloidun farmaseuttisen koostumuksen valmistamiseksi
FI911420L (fi) Menetelmä terapeuttisesti käyttökelpoisten yhdisteiden valmistamiseksi
FI913498A7 (fi) Menetelmä asetaminofeenin valmistamiseksi
FI911812A7 (fi) Menetelmä ksylanaasin valmistamiseksi
FI910366L (fi) Menetelmä deoksimulundokandiinin valmistamiseksi
FI923360A7 (fi) Menetelmä dimetyyliasetoasetamidin valmistamiseksi